AltPep
WA - SeattleBiotechnology
Focus: AltPep is a Seattle-based biotechnology company focused on developing alternating peptides for neurological diseases and gene therapy applications. The company operates as a pre-revenue biotech with a highly specialized therapeutic focus.
Profile data last refreshed 8h ago · AI intelligence enriched 3w ago
Open Jobs
2-1 this month
Stable — net -1 jobs in 30d
1 added, 2 removed. Backfill posture.
Should You Work at AltPep?
AI assessmentAltPep represents a high-risk, high-reward early-stage bet suitable only for scientists comfortable with preclinical risk in exchange for potentially foundational equity upside in a novel modality.
Why Work Here
- Ground-floor opportunity at a company with proprietary alternating peptide platform targeting underserved neurological indications with high unmet medical need
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for AltPep
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.